President Trump’s daughter-in-law, Lara Trump, hinted that other members of the Trump family may seek political office in the future. During an appearance on Miranda Devine’s “Pod Force One” podcast, Lara Trump said she has considering running for U.S. Senate twice. “I have looked at my father-in-law over the past eleven, almost twelve years now, and I’ve watched the impact that he’s been able to make in people’s lives and it’s amazing. Look, he’s dealt with h***, right? He has gone through so much,” Trump said. “So it’s really inspired me, and I think it’s inspired everyone in our family, so much so that I’d consider running for a possible Senate seat. So I would never say never to anything. What I do feel like, and whether it’s for Donald Trump running, who thought about running for president for a long time before he actually did, or a Senate run, or whatever it might be for me or I think anyone in our family, I think the timing has to be right, and it didn’t work out for me in 2022, it didn’t work out for me in 2025. Just the timing had to be right,” she continued. “I would say that at this point, we’ve all kind of dipped our toe in the water of politics enough to know that it’s something that I think possibly interests many of us in our family, and I know the Democrats will love to hear that, that it may not end just with Donald Trump, but I do think the timing has to be right for all of us,” she added. Lara Trump Says ‘Many’ More Members of the Trump Family May Run for Office: ‘It May Not End Just with Donald Trump!’ (WATCH) https://t.co/rgilskKIUy — The Gateway Pundit (@gatewaypundit) February 18, 2026 NJ.com shared further: When asked about how the president has responded to their possible considerations, Trump replied: “I don’t think I’ve had a bigger champion in running for a Senate seat than my father-in-law.” “In fact, so much so, that he would call me multiple times a week with multiple people from different backgrounds to say, ‘This person thinks you’d be great. You got to do it,’” she continued. Neither Donald Trump Jr. nor Eric Trump have indicated whether they intend to run for the Oval Office in the future, but have both appeared to keep their options open. “I don’t know, maybe one day, you know — that calling is there,” Donald Trump Jr. said last May of a future presidential run. “I think my father has truly changed the Republican Party. I think it’s the America First party now, the MAGA party, however you want to look at it.” The following month, Eric Trump said that he sees an “easy” path forward for a family dynasty as he hinted at seeking office once his father ends his time in the White House. Watch Lara Trump’s comments below:

Tech giant and AI leader Palantir has moved its headquarters from Denver, Colorado, to Miami, Florida. “We have moved our headquarters to Miami, Florida,” the company announced on Tuesday. We have moved our headquarters to Miami, Florida. — Palantir (@PalantirTech) February 17, 2026 Palantir, which has faced criticism for its role in expanding government surveillance by utilizing artificial intelligence and facial recognition technology, was the largest publicly traded company in Colorado. The Colorado Sun shared further: Founded by billionaire Peter Thiel and its CEO Alex Karp, Palantir was in the news this month after activists behind the “Purge Palantir” database publicized the company’s donations to two of Colorado’s Democratic members of Congress. U.S. Rep. Jason Crow of Aurora and Sen. John Hickenlooper vowed to donate the funds to immigrant-rights groups. According to Palantir’s latest annual report released Tuesday, the company changed its principal executive office address to 19505 Biscayne Blvd., Suite 2350, in Aventura, which is about 20 miles north of Miami. The report also noted that the Denver location, at 518 17th St., is its former address. Gov. Jared Polis said he was not aware of Palantir’s move before it was announced. “I was not notified,” he said during a news conference Tuesday in his office at the Colorado Capitol. “I don’t know what the announcement means. Obviously, what I would be looking into is: Does it affect any jobs here in Colorado?” Polis said he believes there were as many as 600 people directly or indirectly working for Palantir in Colorado. “I have requested a meeting with executives of the company,” he said. More below: NEW: Palantir, Colorado's most valuable publicly traded company, suddenly departed for Florida today. The Governor and Denver's Mayor say they were blindsided. @Marshall9News reports for @nexton9news: pic.twitter.com/5M3KnckQnH — Kyle Clark (@KyleClark) February 18, 2026 Not all Floridians were enthusiastic about Palantir’s move to the Sunshine State. “As Governor, I will ban you from all government contracts. You are a threat to our civil liberties,” Florida gubernatorial candidate James Fishback commented. As Governor, I will ban you from all government contracts. You are a threat to our civil liberties. https://t.co/jApQ9yEh8m — James Fishback (@j_fishback) February 17, 2026 Fox Business has more: The Florida Council of 100 and local leaders have hailed the move as a “watershed moment” that validates Florida as a hub for national security and AI innovation. “Palantir’s decision to relocate its headquarters to Florida’s Gold Coast is a powerful validation of where growth is happening in America,” Florida Council of 100 President and CEO Michael Simas said in a statement posted on X. “Florida is building the platform for the next generation of high-wage industries, and through Ambition Accelerated, we are aligning leadership and capital to accelerate that future,” Simas continued. Earlier this month, the Council — with the backing of Citadel founder Ken Griffin and Related Companies founder Stephen Ross — announced the “Ambition Accelerated” initiative, which will feature advertising and branding aimed at encouraging decision-makers to build or relocate to South Florida, from West Palm Beach and Fort Lauderdale to Miami.

The Food and Drug Administration has reversed course and will review the application for Moderna’s mRNA-based influenza vaccine. Previously, the vaccine manufacturer said the agency declined to review its application for an “investigational influenza vaccine.” Moderna Says FDA Declined To Review Application For “Investigational” Vaccine "To advance the review, Moderna proposed a regulatory pathway based on age, seeking full approval for adults 50 to 64 years of age and accelerated approval for adults 65 and older, along with a post-marketing requirement to conduct an additional study in older adults," Moderna stated in a release. "Following submission of the amended application, the FDA has accepted the biologics license application (BLA) for review and assigned a Prescription Drug User Fee Act (PDUFA) goal date of August 5, 2026. Pending review and FDA approval, mRNA-1010 would be available for U.S. adults 50 years of age and older, including adults 65 and older, for the 2026/2027 flu season," it continued. "We appreciate the FDA's engagement in a constructive Type A meeting and its agreement to advance our application for review," said Moderna CEO Stéphane Bancel. "Pending FDA approval, we look forward to making our flu vaccine available later this year so that America's seniors have access to a new option to protect themselves against flu," he continued. Today we announced that, in response to a prior Refusal-to-File letter, we engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and proposed a revised regulatory approach for our investigational seasonal influenza vaccine candidate, mRNA-1010. Read more:… pic.twitter.com/ME92rJkNJq — Moderna (@moderna_tx) February 18, 2026 BioSpace has more: The RTF had thrown Moderna’s quest to reach breakeven status by 2028 into question, with William Blair saying in a February 11 note that following the news, they were reworking their models of Moderna’s future potential earnings on the fly. mRNA-1010 is expected to contribute billions in revenue, along with the company’s combo flu/COVID vaccine mRNA-1083. Moderna had been waiting for the regulatory process for mRNA-1010 to advance before moving an application forward for the combo vaccine. Now, order may be restored. On Wednesday, Jefferies noted that by 2027-28, Moderna could launch seven or more products in the respiratory, oncology and rare disease spaces. “Continued cost reductions could allow MRNA to achieve cash breakeven guidance by 2028,” the analysts wrote. "mRNA-1010 has now been accepted for review in the United States, Europe, Canada and Australia with further submissions planned in 2026. Moderna expects the first potential approvals for mRNA-1010 in 2026, subject to various ongoing regulatory reviews," Moderna stated in the release. NPR shared further: Health and Human Services Department spokesman Andrew Nixon said in an emailed statement to NPR last week that "the FDA rejected Moderna's application for filing because the company refused to follow very clear FDA guidance from 2024 to test its product in a clinical trial against a CDC-recommended flu vaccine to compare safety and efficacy." On Wednesday, Nixon said in an email to NPR that the FDA had a meeting with Moderna, leading the company to amend its application for the experimental shot, which the FDA accepted. "FDA will maintain its high standards during review and potential licensure stages as it does with all products," he said. Moderna says it agreed to add a confirmatory study in older adults that will use a high-dose flu shot after the mRNA vaccine is on the market, the company confirmed to NPR.

New York City Mayor Zohran Mamdani proposed canceling plans to hire 5,000 additional police officers in his first preliminary budget. Before he left office, former Mayor Eric Adams proposed that the New York Police Department (NYPD) hire 5,000 more officers. “Mamdani moved to cancel all orders signed by Adams following his Sept. 26, 2024, indictment,” Fox News stated. Among the canceled orders was the plan to hire additional officers. BREAKING: NYC Mayor Zohran Mamdani proposes SLASHING the NYPD budget by $22 MILLION (from $6.4B) and CANCELING 5,000 planned new officer hires from Eric Adams' plan! This scraps the push to grow NYPD to ~40,000 officers, capping it at around 35,000 instead—amid a "historic… pic.twitter.com/QhpwmNTyAs — Thomas Kellogg (@ThomasKelloggNY) February 18, 2026 Fox News explained further: Under Adams’ plan, the NYPD was set to add 300 officers in July 2026, growing to 2,500 in July 2027 and eventually increasing to 5,000 additional officers annually in July 2028. The Adams plan allowed the NYPD to deploy approximately 40,000 officers to the streets, while Mamdani’s plan caps the number closer to its current level of around 35,000. Additionally, in the preliminary FY 2027 budget, it notes the importance of “significantly reducing current vacancies,” which could include reductions in funding for the NYPD based on unfilled positions. The Gothamist, a New York-based publication, noted that Mamdani’s budget proposes a $22 million decrease in the NYPD’s $6.4 billion budget next year. On Tuesday, Mamdani told reporters that New York City was in a budget crisis but said that it was something the city “can and will overcome.” Mamdani said during the Tuesday news conference that his administration had “inherited a historic budget gap” and while it had managed to lower the deficit from $12 billion to $5.4 billion, there was still a “significant chasm.” “I know that for those who have watched budget after budget, it is tempting to assume that we are engaging in the same dance as our predecessors. Let me assure you, nothing about this is typical. That’s why our solutions won’t be either,” Mamdani said. Mamdani has made numerous tax proposals in response to the budget crisis. One option he pushed was raising taxes on wealthy individuals and corporations. Alternatively, he proposed raising property taxes by 9.5% as a last resort. Watch below: Mayor Zohran Mamdani has declared that property taxes will require a 9.5% hike across NYC to make up for Gov. Kathy Hochul's refusal to hike taxes on NY's wealthy. https://t.co/Pm5tpxqBZJ pic.twitter.com/f5JJdM4CqN — New York Post (@nypost) February 17, 2026 Gothamist has more: Police Benevolent Association President Patrick Hendry said the NYPD’s budget has grown while the number of police officers has shrunk. “The bottom line is that the city always finds the money for the priorities it chooses,” he said. “Public safety must be a priority.” The preliminary budget also sets aside $31 million for NYPD security costs related to the 2026 FIFA World Cup; $94 million for the Domain Awareness System, which powers the department’s network of surveillance cameras and drones; $54 million for information technology maintenance; and $44 million to replace aging emergency response vehicles. Beyond the NYPD, the Mayor’s Office of Criminal Justice budget would rise from $798 million to $810 million next year, driven in part by roughly $26 million in annual spending to prevent hate crimes. The budget of the Civilian Complaint Review Board, which investigates misconduct allegations against NYPD officers, would remain roughly flat at about $29 million. District attorney budgets would decline next year, largely because of a drop in state and federal funding, even as the city increases its own contribution.

Environmental activists blasted a House Republican version of the 2026 farm bill that includes a provision shielding pesticide manufacturers from lawsuits alleging they failed to adequately warn about potential harms of their products beyond EPA standards. “It even prevents state Ag Commissioners from regulating misleading labels on pesticides in their own state. It is complete immunity from lawsuits. Our Republican officials are doing the bidding of primarily foreign chemical companies to protect their profits. This is not MAHA,” Moms Across America founder Zen Honeycutt said. The Farm Bill is out and the defacto pesticide immunity shiled is worse than before. It even prevents state Ag Commissioners from regulating misleading labels on pesticides in their own state. It is complete immunity from lawsuits. Our Republican officials are doing the bidding… https://t.co/hIhaJdMgHz — Zen Honeycutt (@zenhoneycutt) February 13, 2026 “The chair of the Agriculture Committee, in releasing the Republican Farm Bill text in three separate sections: (i) prohibits lawsuits by farmers and consumers harmed by pesticides for which manufacturers failed to provide complete safety warnings (Section 10205); (ii) takes away the authority of local governments to protect residents and the local environment from pesticide use (Section 10206), and; (iii) repeals requirements in numerous federal statutes to protect against local pesticide contamination that could affect waterways, drinking water, federal projects, endangered species, migratory birds, and toxic waste (Section 10207),” Beyond Pesticides wrote. “The Federal Farm Bill was released yesterday and it does contain a provision designed to give pesticide manufacturers de facto immunity, Section 10205. As always, the lawyers behind these provisions have drafted the language in a manner which obfuscates its true meaning and impact,” toxicologist and advocate Dr. Alexandra Muñoz commented. “Legislators are being told it’s a provision for uniform labeling for pesticides – but pesticides already have uniform labels. So then what is the true intention of the provision? De facto immunity,” she continued. Pesticide Immunity in the Farm Bill The Federal Farm Bill was released yesterday and it does contain a provision designed to give pesticide manufacturers de facto immunity, Section 10205. As always, the lawyers behind these provisions have drafted the language in a manner… pic.twitter.com/EPwXKh7odJ — Dr. Alexandra Muñoz (@amtoxicology) February 14, 2026 Beyond Pesticides explained further: Expected to be put to a committee vote as early as February 23, the basic right to sue chemical manufacturers for the harm caused by their toxic products and their failure to warn about those hazards is being threatened (Section 10205). Litigation has always been a tool for holding manufacturers accountable for the damages they cause, providing an important check on the marketing of products beyond baseline regulations issued by the U.S. Environmental Protection Agency (EPA). While this has always been of fundamental importance, environmental and public health advocates say it is especially critical with the current dismantling of EPA and deregulation of the chemical industry. “Instead of destroying incentives to ensure corporate responsibility, Congress through the Farm Bill should be facilitating the transition to ecological-based practices, like federally defined organic methods, that address the existential health, biodiversity, and climate issues of our time,” said Jay Feldman, executive director of Beyond Pesticides. Beyond revoking this basic right to be warned of product hazards, the legislation preempts the authority of local governments to protect their residents from pesticide exposure, as determined by state governments (reversing a 1991 U.S. Supreme Court decision in Wisconsin Pub. Intervenor v. Mortier | 501 U.S. 597, 1991) (Section 10206). Furthermore, the bill exempts registered pesticides from further “permitting or approval requirements,” which could include permits to restrict pesticides under the Clean Water Act, requirements for an environmental impact statement under the National Environmental Policy Act, or meet review standards under the Endangered Species Act, Migratory Bird Act, and other statutes affecting pesticide storage, transportation, and toxic waste (Section 10207). Chemical manufacturers, led by Bayer/Monsanto, have been moving across the U.S. with state legislation to shield manufacturers from lawsuits by consumers and farmers who have been damaged by pesticides and not warned of hazards, like cancer. Now, they are moving their chemical company immunity campaign to the U.S. Congress, and then the Supreme Court. This follows years of successful litigation against Monsanto and over $10 billion in jury verdicts and settlements on adverse effects of the weed killer glyphosate/Roundup. According to The Center Square, the Center for Biological Diversity called the bill a “monstrosity” that would “allow foreign-owned pesticide conglomerates to dominate the policies that impact the safety of the food every American eats.” “This Republican Farm Bill proposal is a grotesque, record-breaking giveaway to the pesticide industry that will free Big Ag to accelerate the flow of dangerous poisons into our nation’s food supply and waterways,” Brett Hartl, the organization’s government affairs director, told the outlet. “This bill would block people suffering from pesticide-linked cancers from suing pesticide makers, eviscerate the EPA’s ability to protect rivers and streams from direct pesticide pollution, and give the pesticide industry an unprecedented veto over extinction-preventing safeguards for our nation’s most endangered wildlife,” he added. “It is unbelievable that 800-page bills just appear with representatives who have clearly not read or understood them. We have a government passing legislation written by Big Ag and chemical companies with no regard for public health or safety. People all across the political spectrum have made clear they oppose pesticide immunity or any weirdly worded sections basically allowing it, but industry keeps sneaking it into massive bills,” one X user commented. Important The new Republican House Farm Bill quietly advances pesticide immunity from harm for companies. Sec. 10205: This provision blocks states and local governments from requiring any warnings beyond what the EPA approves, shielding companies from liability. Sec.… pic.twitter.com/mK20gjr9ww — End Tribalism in Politics (@EndTribalism) February 18, 2026 More from The Center Square: Supporters argue the measure will boost the competitiveness of America’s agricultural sector, provide regulatory certainty, and shield corporations from “frivolous” lawsuits. CropLife America, which represents the nation’s pesticide industry, did not respond to The Center Square’s request for comment in time for publication but did release a statement supporting the farm bill draft. “Farmers need continued access to pesticides approved by the Environmental Protection Agency through its rigorous, science-based regulatory process, to protect crops from weeds, pests, and diseases and to remain globally competitive, and we support the inclusion of several important provisions in this bill which support that goal,” CLA President Alexandra Dunn said in a press release. “We look forward to working with members on both sides of the aisle to advance this legislation and secure its passage in 2026 to strengthen and support U.S. agriculture.” Democratic lawmakers have condemned other parts of the farm bill as well, such as a restriction on federal funding of solar projects located on forest or prime farmland. The legislation also transfers authority to administrate the Food for Peace program from the U.S. Agency for International Development to the USDA, a move Democrats and other critics say could endanger the program’s efficiency and effectiveness. With partisanship running high in Congress, it is unclear if enough Democrats will support the 802-page bill, which authorizes funds for crop insurance, disaster assistance, risk management, farm loans, rural energy grants, forest management, and hundreds of other critical bipartisan initiatives. House Agriculture Committee Ranking Member Angi Craig, D-Minn., described the legislation as “a shell of a farm bill with poison pills that complicates if not derails chances of getting anything done.” Read the full 802-page proposed bill HERE (Section 10205 – Section 10207 starts on page 685).